Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 21CNS 6Thoracic 1Sarcoma 1NET 1Head & Neck 1Dermatologic 1

Conditions

Melanoma 317Carcinoma, Non-Small-Cell Lung 72Skin Neoplasms 65Carcinoma, Renal Cell 48Lung Neoplasms 45Breast Neoplasms 45Colorectal Neoplasms 42Carcinoma, Basal Cell 41Neoplasms 40Neoplasm Metastasis 40Squamous Cell Carcinoma of Head and Neck 36Uveal Melanoma 33Ovarian Neoplasms 33Carcinoma, Merkel Cell 32Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 26Prostatic Neoplasms 24Head and Neck Neoplasms 22Stomach Neoplasms 21Thyroid Neoplasms 20Urinary Bladder Neoplasms 19Carcinoma, Hepatocellular 19Uterine Cervical Neoplasms 18Esophageal Neoplasms 18Carcinoma, Squamous Cell 18Mycosis Fungoides 16Carcinoma, Transitional Cell 16Brain Neoplasms 16Recurrence 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Dermatologic × 90 days × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡